Teriparatide injections improve pedicle bone quality

Teriparatide injections improve pedicle bone quality
Daily injection of teriparatide significantly reduces the incidence of pedicle screw loosening at one year following surgery to correct degenerative spondylolisthesis in osteoporotic postmenopausal women, according to a study published in the April 15 issue of Spine.

(HealthDay)—Daily injection of teriparatide significantly reduces the incidence of pedicle screw (PS) loosening at one year following surgery to correct degenerative spondylolisthesis in osteoporotic postmenopausal women, according to a study published in the April 15 issue of Spine.

Seiji Ohtori , M.D., Ph.D., from Chiba University in Japan, and colleagues studied 62 women with osteoporosis diagnosed with degenerative who underwent decompression and one- or two-level instrumented posterolateral fusion with a local . Patients were divided into three groups: a teriparatide group (daily subcutaneous injection of 20 µg of teriparatide; 20 patients), a bisphosphonate group (daily oral administration of 2.5 mg of ; 20 patients), and a control group (no medication for osteoporosis; 22 patients). Radiographic, clinical, and computed tomography evaluations were conducted 12 months after surgery.

The researchers found that at follow-up the incidence of PS loosening was 7 to 13 percent in the teriparatide group, 13 to 26 percent in the risedronate group, and 15 to 25 percent in the control group. In the teriparatide group the incidence of PS loosening was significantly lower than that in the risedronate or the control group. In the risedronate group, PS loosening was not significantly different from that in the control group.

"Our findings suggest that administration of increased the quality of the lumbar spine bone marrow and pedicle cortex," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Teriparatide ups bone union for women with osteoporosis

Nov 03, 2012

(HealthDay)—Injections of teriparatide are more effective than oral bisphosphonate for bone union after instrumented lumbar posterolateral fusion in women with postmenopausal osteoporosis, according to ...

Study tests unilateral versus bilateral lumbar fusion

Apr 09, 2012

(HealthDay) -- For patients with degenerative lumbar diseases, the unilateral pedicle screw (PS) instrumented transforaminal lumbar interbody fusion (TLIF) procedure results in shorter operative time, less ...

Spondylolisthesis linked to spinous process fractures

Jun 02, 2012

(HealthDay) -- There is a strong association between degenerative spondylolisthesis and spinous process fracture in patients undergoing interspinous process spacer (IPS) surgery, according to a study published ...

Recommended for you

Restrictions lifted at British bird flu farm

22 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.